However, the largest Phase IIb trial involving 536 participants failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading to development termination in 2007
For research reference only.
While not typically used as a primary wound healing treatment, it may support recovery from minor injuries, microneedling procedures , or other skin damage
After ordering their product and comparing it to our 1% Super GHK-Cu Serum we could tell that we did not receive what was advertised
therefore a delay is expected in packages shipped during this season
Why Perfect B Is Evaluating AOD 9604: Our Clinical Perspective We began our internal evaluation of AOD 9604 in response to a consistent pattern we were seeing with patients in our South Florida practice: people who had experienced meaningful fat loss on GLP-1 medications, then plateaued or discontinued due to side effects, and were looking for a next option